L'Oréal stock stays supported by its 2025 sales growth

L'Oréal (FR0000125486) remains a large-cap consumer-staples name after reporting 2025 sales of EUR 43.48 billion, up 5.1% like-for-like, with an operating margin of 20.2% and net profit attributable to the Group of EUR 6.41 billion for the year ended 31 December 2025.

2025 sales still set the tone

The company said 2025 sales reached EUR 43.48 billion, while like-for-like growth was 5.1% and the operating margin held at 20.2% in the full year. Net profit attributable to the Group increased to EUR 6.41 billion from EUR 6.18 billion in 2024, giving investors a clear earnings base heading into the next reporting cycle.

The group also continued to convert growth into cash, with net cash generated from operating activities at EUR 6.78 billion in 2025. That matters because it underpins spending on brands, research, and distribution without leaning on leverage.

Margin beats revenue noise

For a business of this scale, the margin line often matters more than a single quarter. L'Oréal's 20.2% operating margin in 2025 showed that pricing, mix, and cost control remained intact even as growth normalized from pandemic-era swings.

Another comparison stands out: net profit attributable to the Group rose by EUR 230 million year on year, from EUR 6.18 billion in 2024 to EUR 6.41 billion in 2025. That is a smaller move than sales, but it signals that earnings still expanded after a year of heavy operating scale.

EUR 529.7 billion market value

At the market level, L'Oréal's capitalization was EUR 529.7 billion on 20 July 2026, versus EUR 457.8 billion at the 2025 year-end reference point used in the available market data. That difference of EUR 71.9 billion equals about 15.7%, a reminder that valuation can move faster than reported sales.

The same dataset shows the shares at EUR 199.84 on 20 July 2026, after a 52-week range of EUR 316.60 to EUR 173.22. The stock therefore sat closer to the lower end of its annual range than to the peak, even after the company protected margins at the operating level.

Skin care drives scale

L'Oréal's Consumer Products, Dermatological Beauty, Professional Products, and Luxe divisions continue to carry the brand portfolio, but dermatological and premium beauty remain especially important for mix. In 2025, the group's reported growth was driven by a broad-based balance across categories rather than one outsized product launch.

For the stock, the product story matters because premium mix can support gross margin more reliably than volume alone. That is why the 2025 margin of 20.2% and the EUR 6.78 billion operating cash generation are more informative than a pure sales headline.

Shares near the range low

The latest market data puts L'Oréal stock at EUR 199.84 as of 20 July 2026, alongside a market capitalization of EUR 529.7 billion and a 52-week span from EUR 173.22 to EUR 316.60. Those three figures together frame the valuation debate more clearly than a one-line price quote.

In practical terms, the business still combines EUR 43.48 billion of annual sales, 5.1% like-for-like growth, and a 20.2% operating margin with a market value that has moved materially from the 2025 baseline. The result is a company whose earnings profile remains steady even when the share price trades well below its yearly high.